Cargando…
Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizum...
Autores principales: | Gallego-Pinazo, Roberto, Dolz-Marco, Rosa, Marín-Lambíes, Cristina, Díaz-Llopis, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619496/ https://www.ncbi.nlm.nih.gov/pubmed/23650454 http://dx.doi.org/10.4137/OED.S7264 |
Ejemplares similares
-
Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
por: Marín-Lambíes, Cristina, et al.
Publicado: (2012) -
Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
por: Martínez-Castillo, Sebastián, et al.
Publicado: (2012) -
Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema
por: Goel, Siddhi, et al.
Publicado: (2019) -
Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
por: Keane, Pearse A, et al.
Publicado: (2011) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
por: Azad, Rajvardhan, et al.
Publicado: (2012)